Forecast: Basic Pharmaceutical Products and Pharmaceutical Preparations Production Value in Sweden

The production value of basic pharmaceutical products and pharmaceutical preparations in Sweden reached 19.42 billion Euros in 2023, continuing a clear upward trend since 2017. This reflects a significant increase from the previous year, with a year-on-year variation of 10.66%. The past two years have seen a robust growth pattern, and the CAGR over the last five years stood at 15.64%, indicating strong market momentum.

From 2024 onwards, the sector is forecasted to maintain its growth trajectory, achieving an average annual growth rate (CAGR) of 6.02% up to 2028. By 2028, the production value is expected to reach 28.49 billion Euros, cumulatively reflecting a 33.97% growth rate over this period. This suggests a sustained positive outlook for the industry.

Future trends to watch for include advancements in biotechnology and personalized medicine, regulatory changes, and the global demand for innovative treatments. Continued investment in R&D and shifts toward more sustainable production methods will also play crucial roles in shaping the industry's trajectory.